Case No. 2017-846
SUMMARY
UCLA researchers from the Department of Medicine have developed novel nanoparticle and imaging methods for the MRI-guided targeted delivery of therapeutic agents.
BACKGROUND
Magnetic Resonance Imaging (MRI) is a widely used diagnostic imaging platform for both anatomical and functional imaging. MRI is increasingly being used in clinical practice to guide, control, and monitor thermal ablation of diseased tissues by non-invasive high-intensity focused ultrasound (HIFU) or minimally invasive near-infrared (NIR) light inside the MRI scanner. However, MRI-guided delivery of targeted agents remains the subject of early stage exploration.
INNOVATION
UCLA researchers have developed novel MRI-guided stimuli-responsive mesoporous silica nanoparticles (MSNs) for targeted delivery of therapeutic agents. New developments in nanoparticle technology have been combined to deliver materials to specific sites of interest at a cellular level, enhance imaging contrast, and enable controlled release of encapsulated agents. With these engineered nanoparticles, MRI can now be used to spatially identify diseased tissue with enhanced dual contrast imaging, and then locally activate the release of therapeutic agents in a controlled signal-targeted manner.
APPLICATIONS
Enhanced dual contrast imaging
Precision delivery of therapeutic agents
ADVANTAGES
Orders of magnitude greater contrast enhancement and detection performance
Precise nanoparticle size uniformity and control
High nanoparticle stability
High agent uptake capacity
Accurate on-demand activation of agent release
RELATED MATERIALS
Ambrogio MW, Thomas CR, Zhao YL, Zink JI, Stoddart JF. Mechanized silica nanoparticles: A new frontier in theranostic nanomedicine. Acc Chem Res 2011;44:903–13. doi:10.1021/ar200018x; PMID:21675720.
Li Z, Barnes JC, Bosoy A, Stoddart JF, Zink JI. Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev 2012;41:2590–605. doi:10.1039/C1CS15246G; PMID:22216418.